September 26, 2023 BERLIN, Germany — Dopavision has successfully completed enrollment for its MyopiaX-1 clinical trial. MyopiaX-1 is a randomized, active-controlled trial...
December 1, 2022 By Nicole Liu, MOptom, PhD Candidate, Brien Holden Vision Institute Seasonal variations in myopia progression have been frequently reported...
August 2, 2021 By Dwight Akerman, OD, MBA, FAAO, FBCLA Several products and interventions — which have been proposed for reducing the...
Sponsored Content Sept. 1, 2020 By Ryan Parker, OD, and Ryan Powell, OD Have sympathy for the parents who come in with...